M&As this week: Lonza Group, Shandong Buchang Pharmaceutical


Swiss biopharmaceutical company Lonza Group has completed the acquisition of HansaBioMed Life Sciences OU, an Estonian pharmaceutical company.

The acquirer company expects the transaction to help develop next-generation research, therapeutic and diagnostic applications based on exosomes.

Shandong Buchang Pharmaceutical has completed the acquisition of Tonghua Guhong Pharmaceutical.

Both companies involved in the acquisition are pharmaceutical firms based in China.